Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-18,564
Closed -$127K 2008
2025
Q1
$127K Buy
18,564
+2,941
+19% +$21.4K ﹤0.01% 1725
2024
Q4
$104K Buy
+15,623
New +$107K ﹤0.01% 1790
2024
Q3
Sell
-7,384
Closed -$81K 2001
2024
Q2
$81K Buy
+7,384
New +$93.6K ﹤0.01% 1733
2023
Q2
Sell
-257
Closed -$10.1K 2106
2023
Q1
$10.1K Buy
+257
New +$10.7K ﹤0.01% 2001
2022
Q4
Sell
-2,110
Closed -$76K 1954
2022
Q3
$76K Buy
+2,110
New +$87.9K ﹤0.01% 1601
2021
Q3
Sell
-10,284
Closed -$583K 1609
2021
Q2
$583K Buy
+10,284
New +$585K ﹤0.01% 1263

Other funds holding NUS

Amundi's NUS Position: Q2 2025 in Review

Amundi sold out of Nu Skin (NUS) in Q2 2025, closing a stake of 18,564 shares — an estimated $127K sold.

Amundi first reported a position in NUS in Q2 2021 and held it in 6 quarters. The position peaked at $583K in Q2 2021. 179 funds tracked by Wall St. Rank hold NUS as of Q2 2025.

  • Amundi reported no remaining Nu Skin position as of Q2 2025 after selling out during the quarter.
  • Amundi sold 18,564 Nu Skin shares in Q2 2025, an estimated $127K.
  • Amundi first reported a position in Nu Skin in Q2 2021 and held it in 6 quarters.
  • Amundi's Nu Skin position peaked at $583K in Q2 2021.
  • 179 funds tracked by Wall St. Rank held Nu Skin as of Q2 2025.

Based on Amundi's 13F filing for Q2 2025, filed 13 Aug 2025.